logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hirotoshi Iihara

Gifu University Hospital
H指数:25
被引数:1,874

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy

中枢神经系统症状负担及奥氮平在AC化疗中抗恶心管理的临床意义

Oncologist
IF4.2
2026-09-090
OAAI
Ryoko Udagawa; Mototsugu Shimokawa; Hirotoshi Iihara; Rie Ozeki; Michiko Tsuneizumi; Manabu Futamura; Tomoyuki Fujita; Hideaki Ogata; Hiroko Bando; Toshitaka Uomori; Hironobu Hashimoto; Ryosuke Hayami; Yoshihisa Tokumaru; Goro Kutomi; Kan Yonemori; Ryoichi Matsunuma; Mika Kitahora; Naotake Yanagisawa; Tatsunori Shimoi; Mitsue Saito; null
Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention

Netupitant与aprepitant的比较：基于模型预测的神经激肽-1受体占有率及其对长效迟发性恶心和呕吐预防的启示

Supportive Care in Cancer
IF3
2026-09-050
OAAI
Hirotoshi Iihara; Giampaolo Bianchini; Matti Aapro; Luca Licata; Alberto Bernareggi; Rudolph M. Navari; Yeon Hee Park; Karin Jordan; María Vidal; Florian Scotté; Eric J. Roeland; Lee Schwartzberg; Hope S. Rugo
Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis

RAS突变型转移性结直肠癌中VEGF抑制剂延长治疗期间的蛋白尿：发生率、中断情况及探索性生存分析

International Journal of Colorectal Disease
IF2.3
2026-08-040
OAAI
Daichi Watanabe; Hironori Fujii; Yuto Miura; Misato Kani; Wakana Chikaishi; Jesse Yu Tajima; Akitaka Makiyama; Yunami Yamada; Koichi Ohata; Chiemi Hirose; Hirotoshi Iihara; Ryo Kobayashi; Nobuhisa Matsuhashi; Akio Suzuki
Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone

低致呕化疗的抗呕吐疗法系统综述：比较5-HT3受体拮抗剂和地塞米松

International Journal of Clinical Oncology
IF2.8
2026-07-210
PRE
Takeshi Aoyama; Hirotoshi Iihara; Masakazu Abe; Makoto Wada; Keiko Iino; Tatsuo Akechi; Chiyo K. Imamura; Ayako Okuyama; Keiko Ozawa; Yong-Il Kim; Hidenori Sasaki; Eriko Satomi; Masayuki Takeda; Ryuhei Tanaka; Takako Eguchi Nakajima; Naoki Nakamura; Junichi Nishimura; Mayumi Noda; Kazumi Hayashi; Takahiro Higashi; Narikazu Boku; Koji Matsumoto; Yoko Matsumoto; Kenji Okita; Nobuyuki Yamamoto; Kenjiro Aogi
Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) — a systematic review and network meta-analysis

奥氮平（10 mg vs 5 mg vs 2.5 mg）预防化疗诱导的恶心和呕吐（CINV）——一项系统评价和网络Meta分析

Supportive Care in Cancer
IF3
2026-07-160
OAAI
Ronald Chow; Daniel Zhang; Gregory W. Chai; Monica Yuen; Angel Lu; Victoria Fortuna; Sumeet Talwar; Gabriel Boldt; Michael Lock; Shing Fung Lee; Lawson Eng; Hirotoshi Iihara; Mary Louise Affronti; Mitsue Saito; Matti Aapro; Paul J. Hesketh; Florian Scotté; Christina H. Ruhlmann; Jennifer Leigh
Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study

益生菌与接受质子泵抑制剂治疗的食管癌患者使用纳武利尤单抗或帕博利珠单抗有效性的关联：一项多中心回顾性研究

Journal of Gastrointestinal Cancer
IF1.6
2026-05-011
PRE
Fujimoto, Ayumi; Uozumi, Ryuji; Fujii, Hironori; Tamaki, Shinya; Eto, Tomoaki; Yamaguchi, Mikumi; Maehara, Yu; Iihara, Hirotoshi; Hatakeyama, Tomoaki; Higuchi, Ayako; Kawazoe, Hitoshi; Ohtani, Hisakazu
Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team

亚洲患者接受化疗或分子靶向治疗联合免疫检查点抑制剂治疗诱导的皮肤毒性：日本药师主导的肿瘤皮肤学研究团队进行的文献综述

International Journal of Clinical Oncology
IF2.8
2026-04-160
OAAI
Yohei Iimura; Junichi Higuchi; Akimitsu Maeda; Kazuhiro Shimomura; Hirotoshi Iihara; Hironori Fujii; Takuya Iwamoto; Yoshitaka Saito; Hisanaga Nomura; Keiko Komori; Hidenori Tokuda; Ryuta Urakawa; Tatsuya Sumiya; Ryosuke Yanai; Mariko Kono; Masaki Ihira; Tomohiro Kurokawa; Yuya Ishii; Masanobu Uchiyama; Teppei Yamada; Yasumasa Tsuda; Yusuke Tsuchiya; Toshinobu Hayashi; Seiichiro Kuroda
Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer

免疫相关不良事件与接受免疫检查点抑制剂联合化疗治疗的肺癌患者生存期的关联

Scientific Reports
IF3.9
2026-04-030
OAAI
Shinya Takada; Izumi Nasu; Ryuji Uozumi; Masahiro Kondo; Shuichi Nawata; Hirotoshi Iihara; Yohei Okumura; Hirokazu Hashishita; Masashi Takemoto; Takahiro Okada; Yu Kitamura; Satoshi Oizumi; Satoshi Fukuda; Sojiro Kusumoto; Junki Endo; Hitoshi Kawazoe; Tomonori Nakamura
Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy

日本接受高或卡铂为基础的中度致吐风险化疗患者的止吐指南依从性研究

International Journal of Clinical Oncology
IF2.8
2025-10-150
PRE
Ayako Okuyama; Takahiro Higashi; Masakazu Abe; Toshinobu Hayashi; Hirotoshi Iihara; Keiko Iino; Chihiro Ishii; Kenji Okita; Makoto Wada; Nobuyuki Yamamoto; Sadamoto Zenda; Kenjiro Aogi; Eriko Satomi
Chemotherapy-related hand–foot syndrome and hand–foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study team

化疗相关性手足综合征和手足皮肤反应：日本药师主导的肿瘤皮肤学研究小组对亚洲患者管理及可能方法的综述

International Journal of Clinical Oncology
IF2.8
2025-10-060
OA
Yohei Iimura; Hirotoshi Iihara; Yoshitaka Saito; Hisanaga Nomura; Takuya Iwamoto; Mayumi Kotera; Yusuke Tsuchiya; Tatsuya Sumiya; Mariko Kono; Daisuke Hirate; Tomohiro Kurokawa; Toshinobu Hayashi; Hironobu Hashimoto; Junichi Higuchi; Ryuta Urakawa; Hiroyuki Saotome; Seiichiro Kuroda
Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team

表皮生长因子受体抑制剂相关皮肤毒性的管理及亚洲患者可能的预防和治疗方法的综述：日本药剂师主导的肿瘤皮肤学研究小组报告

international journal of oncology
IF2.8
2025-09-010
OAAI
Yohei Iimura; Hirotoshi Iihara; Yoshitaka Saito; Hisanaga Nomura; Takuya Iwamoto; Mayumi Kotera; Yusuke Tsuchiya; Tatsuya Sumiya; Mariko Kono; Daisuke Hirate; Tomohiro Kurokawa; Toshinobu Hayashi; Hironobu Hashimoto; Junichi Higuchi; Ryuta Urakawa; Hiroyuki Saotome; Seiichiro Kuroda
Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic score

癌症恶病质发生及生存结局在转移性结直肠癌中的比较评估：亚洲恶病质工作组与欧洲姑息治疗研究合作组织标准的比较评估，以及改良格拉斯哥预后评分的应用价值

International Journal of Colorectal Disease
IF2.3
2025-07-250
OAAI
Hironori Fujii; Misato Kani; Daichi Watanabe; Yuto Miura; Wakana Chikaishi; Jesse Yu Tajima; Akitaka Makiyama; Yunami Yamada; Koichi Ohata; Chiemi Hirose; Hirotoshi Iihara; Ryo Kobayashi; Nobuhisa Matsuhashi; Akio Suzuki
Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial

奥氮平5 mg联合三联止吐药方案用于含蒽环类药物方案乳腺癌患者的总体有效性与安全性：一项III期、双盲、随机、安慰剂对照试验

lancet oncology
IF0
2025-06-180
PRE
Mitsue Saito; Hirotoshi Iihara; Mototsugu Shimokawa; Ryoko Udagawa; Michiko Tsuneizumi; Manabu Futamura; Yuko Ishikawa; Hideaki Ogata; Hiroko Bando; Hiroaki Shima; Keiko Hosoya; Toru Mukohara; Kenichiro Tanaka; Tomoki Ikuta; Takahiko Kawate; Kazushige Ishida; Katsuya Nakai; Toshitaka Uomori; Goro Kutomi; Rie Ozeki; Naotake Yanagisawa
Efficacy of triplet antiemetic prophylaxis against chemotherapy-induced nausea and vomiting in patients with soft tissue sarcomas receiving consecutive-day doxorubicin and ifosfamide therapy

软组织肉瘤患者在接受连续日多柔比星和异环磷酰胺疗法时，三联抗呕吐预防方案对化疗引起的恶心和呕吐的疗效

SUPPORTIVE CARE IN CANCER
IF3
2025-03-130
PRE
Yamada, Yunami; Iihara, Hirotoshi; Nagano, Akihito; Fujii, Hironori; Tsugita, Masanori; Hoshino, Ryo; Hara, Koki; Kobayashi, Ryo; Akiyama, Haruhiko; Suzuki, Akio

研究方向

暂未获取到该数据
A
Akio Suzuki
H 指数:34论文数:463被引数:4,819
H
Hironori Fujii
H 指数:27论文数:306被引数:2,325
H
Hitoshi Kawazoe
H 指数:14论文数:106被引数:679
D
Daichi Watanabe
H 指数:10论文数:81被引数:308
R
Ryuji Uozumi
H 指数:26论文数:153被引数:2,484
C
Chiemi Hirose
H 指数:10论文数:42被引数:344
M
Mototsugu Shimokawa
H 指数:39论文数:576被引数:6,270
M
Masami Tsuchiya
H 指数:17论文数:154被引数:932
M
Manabu Futamura
H 指数:30论文数:242被引数:3,549
R
Ryo Kobayashi
H 指数:15论文数:66被引数:613